Intra-Cellular Therapies (ITCI) PT Lowered to $21 at JMP

JMP Securities analyst Jason Butler lowered the price target on Intra-Cellular Therapies (NASDAQ: ITCI) to $21.00 (from $24.00) while maintaining a Market Outperform rating.

https://www.streetinsider.com/Analyst+PT+Change/Intra-Cellular+Therapies+%28ITCI%29+PT+Lowered+to+%2421+at+JMP+Securities/15792342.html